New oral diabetes drug shows promise for type 1 patients

A Phase 3 clinical trial of the drug, sotagliflozin, show promise at helping to control glucose levels and reduce the need for insulin in type 1 diabetics.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news